Eicosanoids and the endogenous control of acute inflammatory resolution.
Inflammation is a formidable ally in the constant battle against infection, cancer and tissue injury. It is a primordial response that protects against injury and restores damaged tissue to its normal physiological functioning. In fact, our wellbeing and survival depends upon its efficiency and carefully balanced control. In general, the innate inflammatory response initiates within minutes and, if all is well, resolves within hours. In contrast, chronic inflammation persists for weeks, months or even years. Here, we are going to discuss the key endogenous checkpoints necessary for mounting an effective yet limited inflammatory response and the crucial biochemical pathways necessary to prevent its persistence. In this setting, the biochemical synthesis of key pro-resolution eicosanoids as well as their mode of action in self-limiting inflammation will be discussed.
Gilroy
Derek W
DW
Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, 5 University Street, University College London, London WC1E 6JJ, United Kingdom. d.gilroy@ucl.ac.uk <d.gilroy@ucl.ac.uk>
D000208:Acute Disease; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D015777:Eicosanoids / Q000276:immunology*; D025461:Feedback, Physiological; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D007249:Inflammation; D009569:Nitric Oxide / Q000276:immunology
D015777:Eicosanoids; D009569:Nitric Oxide; D001241:Aspirin